Real-World Safety of Second-Line Diabetes Drugs in Elderly
In a groundbreaking advancement for diabetes care, particularly for the elderly population, recent research has provided comprehensive real-world evidence assessing the comparative safety of second-line antihyperglycemic agents in older adults diagnosed with...
Read moreDetails

